Last reviewed · How we verify
NCT05107791
Effects of Stulln and Accommodative Training
Phase 1, PHASE2 trial testing Stulln Eyedrops in Accommodation Disorder. Withdrawn.
31 August 2021
Quick facts
| Lead sponsor | Pacific University |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Start date | 15 March 2021 |
| Primary completion | 31 August 2021 |
| Estimated completion | 31 August 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stulln Eyedrops — full drug profile →
- Thera Tears — full drug profile →
Conditions studied
- Accommodation Disorder — all drugs for Accommodation Disorder →
- Visual Fatigue — all drugs for Visual Fatigue →
Sponsor
Pacific University
Who can join
Adults 18 to 35, any sex, with Accommodation Disorder or Visual Fatigue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study tests the hypothesis that Stulln eyedrops improve accommodative functions by improving the short term facility of ciliary muscles that can be transferred into long-term adaptation. To test this, the investigators propose to conduct a prospective randomized control trials where participants with accommodative dysfunctions are randomly assigned to four groups: control, Stulln only and Stulln plus vision training. The investigators' theory predicts that the efficacy of Stulln will be augmented by vision training.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05107791
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Pacific University trials
Trials by the same sponsor.
- NCT07144774 — Wearable Devices on Health Promotion in Diabetes · NA · completed
- NCT05629637 — Feasibility and Acceptability of Mindfulness-based Resilience Training for Rural Law Enforcement Officers · NA · completed
- NCT05087121 — A Pilot Study of Cognitive Behavioral Therapy - Insomnia (CBT-I) Among Professional Firefighters · NA · completed
- NCT03784846 — Mindfulness-Based Resilience Training for Aggression, Health, and Stress Among Law Enforcement Officers · NA · completed
- NCT04747704 — Three-Principles Approach for Incarcerated Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05107791 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pacific University
- Last refreshed: 21 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05107791.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing